Inconsistencies in the drug use process

Annals of Pharmacotherapy

Volumn 24, Issue 6, 1990, Pages 633-636

  Hutchinson, Richard A ^a   Lewis, Richard K ^b   Hatoum, Hind T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; DRUG COST; DRUG INDUSTRY; DRUG USE; ECONOMIC ASPECT; EDITORIAL; PRIORITY JOURNAL;

COST-BENEFIT ANALYSIS; DRUG INDUSTRY; DRUG THERAPY; DRUG UTILIZATION; UNITED STATES;

EID: 0025334408     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809002400615     Document Type: Editorial

References (36)

1. Task force on prescription drugs: final report. Washington, DC: US Department of Health, Education, and Welfare, 1969.
2. Meyer BR. Improving medical education in therapeutics. Health and Public Policy Committee, American College of Physicians. Ann Intern Med 1988; 108: 145–7.
3. Manasse HR Jr. Medication use in an imperfect world: Drug misadventuring as an issue of public policy, part I and II. Am J Hosp Pharm 1989; 46: 929–44, 1141–52.
4. Hutchinson RA Witte KW. How to get started. Planning clinical pharmacy services. In: Ray M, ed. Basic skills in clinical pharmacy practice. Chapel Hill, NC: Universal Printing and Publishing, 1983: 21–46.
5. Manning PR Lee PV Clintworth WA, et al. Changing prescribing practices through individual continuing education. JAMA 1986; 256: 230–2.
6. Shapiro M Townsend TR Rosner B Kass EH. Use of antimicrobial drugs in general hospitals: Patterns of prophylaxis. N Engl J Med 1979; 301: 351–5.
7. Stone HH Hanley BB Kolb LD, et al. Prophylactic and preventative antibiotic therapy: Timing, duration, and economics. Ann Surg 1979; 189: 691–9.
8. Gagnon JP. Physician prescribing habits. In: Smith MC, ed. Principles of pharmaceutical marketing. 3rd ed. Philadelphia: Lea & Febiger, 1983: 68–87.
9. Davis NM Cohen MR. Medication errors: causes and prevention. Philadelphia: George F. Stickley, 1981.
10. Avorn J Soumerai SB. Improving drug-therapy decisions through educational outreach: A randomized controlled trial of academically based “detailing.” N Engl J Med 1983; 308: 1457–63.
11. Baum C Kennedy DL Forbes MB, et al. Drug use and expenditures in 1982. JAMA 1985; 253: 382–6.
12. Smith MC. Drug product advertising and prescribing: A review of the evidence. Am J Hosp Pharm 1977; 34: 1208–24.
13. Klein T. Detailing and other forms of promotion. In: Smith MC, ed. Principles of pharmaceutical marketing. 3rd ed. Philadelphia: Lea & Febiger, 1983: 400–17.
14. Brink CJ. Reading with a critical eye (editorial). Am J Hosp Pharm 1986; 43: 1697.
15. Relman AS. Journals. In: Warren KS, ed. Coping with the biomedical literature: A primer for the scientist and the clinician. New York: Praeger Publishers, 1981: 67–78.
16. Burkle WS Gwizdala CJ. Evaluation of “toxic” serum theophylline concentrations. Am J Hosp Pharm 1981; 38: 1164–6.
17. Kimelblatt BJ Lerro RC Franchak N, et al. Use review of cimetidine injection. Am J Hosp Pharm 1982; 39: 311.
18. Perlstein PH Callison C White M, et al. Errors in drug computation during newborn intensive care. Am J Dis Child 1979; 133: 376–9.
19. Barker KN McConnell WE. The problems of detecting medication errors in hospitals. Am J Hosp Pharm 1962; 19: 360–9.
20. Black HJ. Unit dose drug distribution: A 20-year perspective. Am J Hosp Pharm 1984; 41: 2086–8.
21. Koren G Barzilay Z Greenwald M. Tenfold errors in administration of drug doses: A neglected iatrogenic disease in pediatrics. Pediatrics 1986; 77: 848–9.
22. Barker KN Harris JA Webster DB, et al. Consultant evaluation of a hospital medication system: Analysis of the existing system. Am J Hosp Pharm 1984; 41: 2009–16.
23. Nichols B. Standardized education for nursing. Am J Hosp Pharm 1981; 38: 1455–8.
24. Jozefczyk KG Schneider PJ Pathak DS. Medication errors in a pharmacy-coordinated drug administration program. Am J Hosp Pharm 1986; 43: 2464–7.
25. Elenbaas RM. When to monitor blood drug levels. Hosp Ther 1986; (July):27–37.
26. Guernsey BG Ingrim NB Hokanson JA, et al. A utilization review of theophylline assays: Sampling patterns and use. Drug Intell Clin Pharm 1984; 18: 906–12.
27. Smith M Murphy JE Job ML Ward ES. Aminoglycoside monitoring: Use of a pharmacokinetic service versus physician recommendations. Hosp Formul 1987; 22: 92–102.
28. Winter ME Herfindal ET Bernstein LR. Impact of decentralized pharmacokinetics consultation service. Hosp Phys 1986; 43: 2178–84.
29. Steel K Gertman PM Crescenzi C Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med 1981; 304: 638–42.
30. Karch FE Lasagna L. Adverse drug reactions: A critical review. JAMA 1975; 234: 1236–41.
31. Porter J Jick H. Drug-related deaths among medical inpatients. JAMA 1977; 237: 879–81.
32. Spino M Sellers EM Kaplan HL. Effect of adverse drug reactions on the length of hospitalization. Am J Hosp Pharm 1978; 35: 1060–4.
33. Garnett WR. Adverse drug reactions: Detection, assessment, reporting, and prevention. In: Ray M, ed. Basic skills in clinical pharmacy practice. Chapel Hill, NC: Universal Printing and Publishing, 1983: 209–49.
34. Blackwell B. The drug defaulter. Clin Pharmacol Ther 1972; 13: 841–8.
35. Bartlett EE. How can patient education contribute to improved health care under prospective pricing? Health Policy 1986; 6: 283–94.
36. Soflin D Young WW Clayton BD. Development and evaluation of an individual patient education program about digoxin. Am J Hosp Pharm 1977; 34: 367–71.